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Asthma in Michigan
Asthma is a chronic lung disease that affects an estimated 16.4 million adults (aged ≥ 18 years)1 and 7.0 million children (aged< 18 
years)1 in the United States (U.S.), regardless of age, sex, race, or ethnicity. Although the exact cause of asthma is unknown and it  
cannot be cured, it can be controlled with self-management education, appropriate medical care, and avoiding exposure to 
environmental triggers. The following data provide an overview of the burden of asthma in Michigan (MI) compared with the U.S.  
All stated comparisons (e.g., higher, lower, similar) indicate that the group is statistically significantly different than the 
reference group (e.g., adults aged 18-24 years, men, non-Hispanic whites, children aged 15-17 years, and boys).
Asthma Prevalence 
In 2008, an estimated 750,954 adults in Michigan had asthma. 
Adult lifetime asthma prevalence was 15.4% and adult current 
asthma prevalence was 9.9% compared with U.S. rates of 13.3% 
and 8.5%, respectively2.
Adult Current Asthma Prevalence by Age, BRFSS, 2008
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Adult current asthma prevalence was lower among adults aged 25+ years than 
adults aged 18-24 years in Michigan. A similar pattern occurred throughout the U.S.
Adult Current Asthma Prevalence by Sex, BRFSS, 2008
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Adult current asthma prevalence was higher among women than 
men in Michigan. A similar pattern occurred throughout the U.S.
Adult Current Asthma Prevalence by Race/Ethnicity, BRFSS, 2008
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Adult current asthma prevalence was higher among non-Hispanic multirace 
persons than non-Hispanic whites in Michigan; however, rates were higher among 
non-Hispanic multirace persons and non-Hispanic blacks throughout the U.S.
In 2008, an estimated 254,583 children in Michigan had 
asthma. Child lifetime asthma prevalence was 15.5% and child 
current asthma prevalence was 10.7% compared with the 38 
participating states’ rates of 13.3% and 9.0%, respectively2.
Child Current Asthma Prevalence by Age, BRFSS, 2008
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Child current asthma prevalence was lower among children aged 0-4 years than children aged 
15-17 years in Michigan. A similar pattern occurred throughout the 38 participating states.
Child Current Asthma Prevalence by Sex, BRFSS, 2008
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Child current asthma prevalence was higher among boys than girls in Michigan. 
A similar pattern occurred throughout the 38 participating states.
Child Current Asthma Prevalence by Race/Ethnicity, BRFSS, 2008
Child current asthma prevalence was higher among non-Hispanic multirace persons and 
non-Hispanic blacks than non-Hispanic whites in  
Michigan. A similar pattern occurred throughout 
the 38 participating states. 
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Asthma in Michigan
Asthma Hospitalizations
Michigan Hospital Discharge Data, 2008
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The age-adjusted asthma hospitalization rate in Michigan was 
162.3/100,000 persons3 compared with the U.S. rate of 144/100,000 
persons4. In Michigan, the hospitalization rate for children was 
179.6/100,000 persons3 and for adults was 159.6/100,000 persons3.
Asthma Deaths
Age-Adjusted Asthma Mortality Rate by Race, NVSS, 2007
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Asthma was the underlying cause of death for 120 adults and 
12 children in Michigan5. The age-adjusted mortality rate in 
Michigan was 12.7/million and the U.S. rate was 11.0/million5.
**The estimate is supressed.
Asthma Patient Education and Medication Use
The National Heart, Lung, and Blood Institute (NHLBI) Expert Panel Report 3: Guidelines for the Diagnosis and Management of 
Asthma includes recommendations by medical and public health experts to aid in the clinical practice of managing asthma.  
The NHLBI Guidelines focus on four areas of asthma management and care: Assessment and Monitoring, Patient Education, Control 
of Environmental Factors Contributing to Asthma Severity, and Pharmacologic Treatment. Items included in the following table are 
related to asthma patient education and medication use for adults with current asthma in Michigan.
Patient Education: Adults with Current Asthma6 Respondents Yes 
Ever taught how to recognize early signs or symptoms of an asthma episode 510 58%
Ever told what to do during an asthma attack 503 70%
Ever taught how to use a peak flow meter to adjust daily medications 511 37%
Ever given an asthma action plan 502 21%
Ever taken a course on how to manage asthma 517 4%
blank row
Medication Use: Adults with Current Asthma6 Respondents Yes
Used a prescription asthma medication in the past 3 months7 512 74%
Notes:
National Health Interview Survey (NHIS), 20081. 
Behavioral Risk Factor Surveillance System (BRFSS), 2008 2. 
When the sample size is fewer than 50, prevalence estimates are considered unstable and should be interpreted with caution. Indicated with an asterisk (*) 
All stated comparisons (e.g., higher, lower, similar) indicate that the group is statistically significantly different than the reference group (e.g., adults aged 18-24 years, men, 
non-Hispanic whites, children aged 15-17 years, and boys).
State Hospital Discharge Data, 2008 3. 
National Hospital Discharge Survey, 2008 4. 
When estimates are based on fewer than 60 hospitalizations, they are considered unstable and should be interpreted with caution. Indicated with an asterisk (*)
National Vital Statistics System (NVSS), 2007 5. 
When estimates are based on fewer than 20 deaths in the numerator, they are considered unstable and should be interpreted with caution. Indicated with an asterisk (*) 
When estimates are based on fewer than 10 deaths in the numerator, data are suppressed due to confidentiality. Indicated with double asterisks (**)
Asthma Call-back Survey, 20086. 
Medication includes inhalers, pills, syrups, and nebulizers.7. 
CDC’s National Asthma Control Program 
For more information on asthma:
http://www.cdc.gov/asthma
http://www.getasthmahelp.org/
